TARDBP and neurodegenerative disease: Other proteins implicated in neurodegenerative diseases, such as TDP-43 and a-synuclein, can also adopt cytosolic fibrillar aggregates with disease-specific conformations.3,4 Based on this evidence, considerable effort is being expended to prevent or reverse ordered protein aggregation as a disease-modifying therapeutic strategy for neurodegenerative diseases.